These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 14745929)
21. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid. Zlotogora J; Amitai Y; Leventhal A Isr Med Assoc J; 2006 Sep; 8(9):601-4. PubMed ID: 17058407 [TBL] [Abstract][Full Text] [Related]
22. Economic evaluation of folic acid food fortification in The Netherlands. Jentink J; van de Vrie-Hoekstra NW; de Jong-van den Berg LT; Postma MJ Eur J Public Health; 2008 Jun; 18(3):270-4. PubMed ID: 18238826 [TBL] [Abstract][Full Text] [Related]
23. [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report]. Meijer WM; de Walle HE Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2561-4. PubMed ID: 16320666 [TBL] [Abstract][Full Text] [Related]
24. [Frequency of neural tube defects in public maternity during 1999 in Santiago, Chile]. Cortés F; Mellado C; Hertrampf E; Alliende A; Castillo S Rev Med Chil; 2001 Mar; 129(3):277-84. PubMed ID: 11372295 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of neural tube defects and folic acid knowledge and consumption--Puerto Rico, 1996-2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Jan; 57(1):10-3. PubMed ID: 18185495 [TBL] [Abstract][Full Text] [Related]
26. Method of weighted proportion of reproductive-aged women taking folic acid supplements to predict a neural tube defect rate decline. Yang Q; Atkinson M; Erickson JD Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):959-67. PubMed ID: 14745914 [TBL] [Abstract][Full Text] [Related]
27. Economic evaluation of a neural tube defect recurrence-prevention program. Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415 [TBL] [Abstract][Full Text] [Related]
28. Awareness and use of folic acid, and blood folate concentrations among pregnant women in northern China--an area with a high prevalence of neural tube defects. Ren A; Zhang L; Li Z; Hao L; Tian Y; Li Z Reprod Toxicol; 2006 Oct; 22(3):431-6. PubMed ID: 16549319 [TBL] [Abstract][Full Text] [Related]
29. Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México. Martínez de Villarreal L; Pérez JZ; Vázquez PA; Herrera RH; Campos Mdel R; López RA; Ramírez JL; Sánchez JM; Villarreal JJ; Garza MT; Limón A; López AG; Bárcenas M; García JR; Domínguez AS; Nuñez RH; Ayala JL; Martínez JG; González MT; Alvarez CG; Castro RN Teratology; 2002 Nov; 66(5):249-56. PubMed ID: 12397633 [TBL] [Abstract][Full Text] [Related]
30. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Ray JG; Wyatt PR; Vermeulen MJ; Meier C; Cole DE Obstet Gynecol; 2005 Feb; 105(2):261-5. PubMed ID: 15684149 [TBL] [Abstract][Full Text] [Related]
31. A decreasing rate of neural tube defects following the recommendations for periconceptional folic acid supplementation. Klusmann A; Heinrich B; Stöpler H; Gärtner J; Mayatepek E; Von Kries R Acta Paediatr; 2005 Nov; 94(11):1538-42. PubMed ID: 16303691 [TBL] [Abstract][Full Text] [Related]
32. Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002. Ward M; Hutton J; Mc Donnell R; Bachir N; Scallan E; O'Leary M; Hoey J; Doyle A; Delany V; Sayers G Ir Med J; 2004 Oct; 97(9):274-6. PubMed ID: 15568585 [TBL] [Abstract][Full Text] [Related]
33. Spina bifida before and after folic acid fortification in Canada. De Wals P; Tairou F; Van Allen MI; Lowry RB; Evans JA; Van den Hof MC; Crowley M; Uh SH; Zimmer P; Sibbald B; Fernandez B; Lee NS; Niyonsenga T Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):622-6. PubMed ID: 18655127 [TBL] [Abstract][Full Text] [Related]
34. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Roberts HE; Moore CA; Cragan JD; Fernhoff PM; Khoury MJ Pediatrics; 1995 Nov; 96(5 Pt 1):880-3. PubMed ID: 7478829 [TBL] [Abstract][Full Text] [Related]
35. Surveillance of neural tube defects in Israel. Zlotogora J; Amitai Y; Kaluski DN; Leventhal A Isr Med Assoc J; 2002 Dec; 4(12):1111-4. PubMed ID: 12516902 [TBL] [Abstract][Full Text] [Related]
36. Folic acid and the decline in neural tube defects in Arkansas. Mosley BS; Hobbs CA; Flowers BS; Smith V; Robbins JM J Ark Med Soc; 2007 Apr; 103(10):247-50. PubMed ID: 17487022 [TBL] [Abstract][Full Text] [Related]
37. Case for mandatory fortification of food with folate in Australia, for the prevention of neural tube defects. Bower C; Stanley FJ Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):842-3. PubMed ID: 15523662 [TBL] [Abstract][Full Text] [Related]
38. Reduction in orofacial clefts following folic acid fortification of the U.S. grain supply. Yazdy MM; Honein MA; Xing J Birth Defects Res A Clin Mol Teratol; 2007 Jan; 79(1):16-23. PubMed ID: 17177274 [TBL] [Abstract][Full Text] [Related]
39. Neural tube defect rates before and after food fortification with folic acid. Mills JL; Signore C Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):844-5. PubMed ID: 15468072 [TBL] [Abstract][Full Text] [Related]
40. [Sex distribution of neural tube defects and their birth outcome in high- and low-prevalence areas of China]. Pei LJ; Li Z; Li S; Hong SX; Wang H; Wang TM; Zhao XQ; Guan YB; Xiao L; Wang LN Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Sep; 37(5):338-41. PubMed ID: 14680596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]